Advertisement

Identification of rs11615992 as a novel regulatory SNP for human P2RX7 by allele-specific expression

  • Tao Peng
  • Li Zhong
  • Jing Gao
  • Zhu Wan
  • Wei-Ping FuEmail author
  • Chang SunEmail author
Original Article
  • 45 Downloads

Abstract

P2RX7 (purinergic receptor P2X 7) is an important membrane ion channel and involved in multiple physiological processes. One non-synonymous SNP on P2RX7, rs3751143, had been proven to reduce ion channel function and further associated with multiple diseases. However, it was still unclear whether there were other cis-regulatory elements for P2RX7, which might further contribute to related diseases. Allele-specific expression (ASE) is a robust and sensitive approach to identify the potential functional region in human genome. In the current study, we measured ASE on rs3751143 in lung tissues and observed a consistent excess of A allele over C (P = 0.001), which indicated that SNP(s) in linkage disequilibrium (LD) could regulate P2RX7 expression. By analyzing the 1000 genomes project data for Chinese, one SNP locating ~ 5 kb away and downstream of P2RX7, rs11615992, was disclosed to be in strong LD with rs3751143. The dual-luciferase assay confirmed that rs11615992 could alter target gene expression in lung cell line. Through chromosome conformation capture, it was verified that the region surrounding rs11615992 could interact with P2RX7 promoter and effect as an enhancer. By chromatin immunoprecipitation, the related transcription factor POU2F1 (POU class 2 homeobox 1) was recognized to bind the region spanning rs11615992. Our work identified a novel long-distance cis-regulatory SNP for P2RX7, which might contribute to multiple diseases.

Keywords

Allele-specific expression (ASE) P2RX7 rs11615992 rs3751143 Enhancer Expression regulation 

Notes

Acknowledgements

We thank Ms. Catherine Southard for language editing. We are also grateful to the two anonymous reviewers for their helpful comments.

Funding

This work was supported by the Fundamental Research Funds for the Central Universities (GK201703031 and GK201701005) for Chang Sun and Joint project of Yunnan Provincial Science and Technology Department and Kunming Medical University (2017FE467-030) and High-Level Talent Training Program in Yunnan (D-201662) for Wei-Ping Fu.

Compliance with ethical standards

Conflict of interest

The authors declare that we have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.

Supplementary material

438_2019_1598_MOESM1_ESM.doc (114 kb)
Supplementary material 1 (DOC 113 kb)

References

  1. Agrawal A, Gartland A (2015) P2X7 receptors: role in bone cell formation and function. J Mol Endocrinol 54:R75–R88CrossRefGoogle Scholar
  2. Alshammari EM, Mandal RK, Wahid M, Dar SA, Jawed A, Areeshi MY, Khan S, Khan ME, Panda AK, Haque S (2016) Genetic association study of P2x7 A1513C (rs 3751143) polymorphism and susceptibility to pulmonary tuberculosis: a meta-analysis based on the findings of 11 case-control studies. Asian Pac J Trop Med 9:1150–1157CrossRefGoogle Scholar
  3. Alves LA, Bezerra RJ, Faria RX, Ferreira LG, da Silva Frutuoso V (2013) Physiological roles and potential therapeutic applications of the P2X7 receptor in inflammation and pain. Molecules 18:10953–10972CrossRefGoogle Scholar
  4. Areeshi MY, Mandal RK, Panda AK, Haque S (2013) Association of P2X7 A1513C (rs3751143) gene polymorphism with risk of tuberculosis: evidence from a meta-analysis. Genet Test Mol Biomarkers 17:662–668CrossRefGoogle Scholar
  5. Bartlett R, Stokes L, Sluyter R (2014) The P2X7 receptor channel: recent developments and the use of P2X7 antagonists in models of disease. Pharmacol Rev 66:638–675CrossRefGoogle Scholar
  6. Beaucage KL, Xiao A, Pollmann SI, Grol MW, Beach RJ, Holdsworth DW, Sims SM, Darling MR, Dixon SJ (2014) Loss of P2X7 nucleotide receptor function leads to abnormal fat distribution in mice. Purinergic Signal 10:291–304CrossRefGoogle Scholar
  7. Bray NJ, O’Donovan MC (2006) Investigating cis-acting regulatory variation using assays of relative allelic expression. Psychiatr Genet 16:173–177CrossRefGoogle Scholar
  8. Bray NJ, Buckland PR, Williams NM, Williams HJ, Norton N, Owen MJ, O’Donovan MC (2003) A haplotype implicated in schizophrenia susceptibility is associated with reduced COMT expression in human brain. Am J Hum Genet 73:152–161CrossRefGoogle Scholar
  9. Buell GN, Talabot F, Gos A, Lorenz J, Lai E, Morris MA, Antonarakis SE (1998) Gene structure and chromosomal localization of the human P2X7 receptor. Receptors Channels 5:347–354Google Scholar
  10. Cheung VG, Conlin LK, Weber TM, Arcaro M, Jen KY, Morley M, Spielman RS (2003) Natural variation in human gene expression assessed in lymphoblastoid cells. Nat Genet 33:422–425CrossRefGoogle Scholar
  11. Chi X, Song S, Cai H, Chen J, Qi Y (2019) Associations of P2X7 polymorphisms with the odds of tuberculosis: a meta-analysis. Int Arch Allergy Immunol 179:74–80CrossRefGoogle Scholar
  12. Dastgheib SA, Gartland A, Tabei SM, Omrani GR, Teare MD (2016) A candidate gene association study of bone mineral density in an Iranian population. Front Endocrinol (Lausanne) 7:141CrossRefGoogle Scholar
  13. Duan S, Yu J, Han Z, Cheng Z, Liang P (2016) Association between P2RX7 gene and hepatocellular carcinoma susceptibility: a case-control study in a Chinese Han population. Med Sci Monit 22:1916–1923CrossRefGoogle Scholar
  14. Ge HB, Chen S (2016) A meta-analysis of P2X7 gene-1513A/C polymorphism and pulmonary tuberculosis susceptibility. Hum Immunol 77:126–130CrossRefGoogle Scholar
  15. Ghalali A, Wiklund F, Zheng H, Stenius U, Hogberg J (2014) Atorvastatin prevents ATP-driven invasiveness via P2X7 and EHBP1 signaling in PTEN-expressing prostate cancer cells. Carcinogenesis 35:1547–1555CrossRefGoogle Scholar
  16. Gidlof O, Smith JG, Melander O, Lovkvist H, Hedblad B, Engstrom G, Nilsson P, Carlson J, Berglund G, Olsson S, Jood K, Jern C, Norrving B, Lindgren A, Erlinge D (2012) A common missense variant in the ATP receptor P2X7 is associated with reduced risk of cardiovascular events. PLoS ONE 7:e37491CrossRefGoogle Scholar
  17. Gong QY, Chen Y (2015) Correlation between P2X7 receptor gene polymorphisms and gout. Rheumatol Int 35:1307–1310CrossRefGoogle Scholar
  18. Gu BJ, Wiley JS (2018) P2X7 as a scavenger receptor for innate phagocytosis in the brain. Br J Pharmacol 175:4195–4208CrossRefGoogle Scholar
  19. Gu BJ, Zhang W, Worthington RA, Sluyter R, Dao-Ung P, Petrou S, Barden JA, Wiley JS (2001) A Glu-496 to Ala polymorphism leads to loss of function of the human P2X7 receptor. J Biol Chem 276:11135–11142CrossRefGoogle Scholar
  20. Hagege H, Klous P, Braem C, Splinter E, Dekker J, Cathala G, de Laat W, Forne T (2007) Quantitative analysis of chromosome conformation capture assays (3C-qPCR). Nat Protoc 2:1722–1733CrossRefGoogle Scholar
  21. Khakh BS, North RA (2006) P2X receptors as cell-surface ATP sensors in health and disease. Nature 442:527–532CrossRefGoogle Scholar
  22. Kim DK, Cho MH, Hersh CP, Lomas DA, Miller BE, Kong XY, Bakke P, Gulsvik A, Agusti A, Wouters E, Celli B, Coxson H, Vestbo J, MacNee W, Yates JC, Rennard S, Litonjua A, Qiu WL, Beaty TH, Crapo JD, Riley JH, Tal-Singer R, Silverman EK, Investigator E, Investigator I, Investigator C (2012) Genome-wide association analysis of blood biomarkers in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 186:1238–1247CrossRefGoogle Scholar
  23. Lees MP, Fuller SJ, McLeod R, Boulter NR, Miller CM, Zakrzewski AM, Mui EJ, Witola WH, Coyne JJ, Hargrave AC, Jamieson SE, Blackwell JM, Wiley JS, Smith NC (2010) P2X7 receptor-mediated killing of an intracellular parasite, Toxoplasma gondii, by human and murine macrophages. J Immunol 184:7040–7046CrossRefGoogle Scholar
  24. Lin L, Huang M, Shi X, Mayakonda A, Hu K, Jiang YY, Guo X, Chen L, Pang B, Doan N, Said JW, Xie J, Gery S, Cheng X, Lin Z, Li J, Berman BP, Yin D, Lin DC, Koeffler HP (2018) Super-enhancer-associated MEIS1 promotes transcriptional dysregulation in Ewing sarcoma in co-operation with EWS-FLI1. Nucleic Acids Res 47:1255–1267CrossRefGoogle Scholar
  25. Liu W, Innocenti F, Wu MH, Desai AA, Dolan ME, Cook EH Jr, Ratain MJ (2005) A functional common polymorphism in a Sp1 recognition site of the epidermal growth factor receptor gene promoter. Cancer Res 65:46–53Google Scholar
  26. Liu H, Han X, Li Y, Zou H, Xie A (2013) Association of P2X7 receptor gene polymorphisms with sporadic Parkinson’s disease in a Han Chinese population. Neurosci Lett 546:42–45CrossRefGoogle Scholar
  27. Mehta N, Kaur M, Singh M, Chand S, Vyas B, Silakari P, Bahia MS, Silakari O (2014) Purinergic receptor P2X(7): a novel target for anti-inflammatory therapy. Bioorg Med Chem 22:54–88CrossRefGoogle Scholar
  28. North RA (2016) P2X receptors. Philos Trans R Soc Lond B Biol Sci 371:20150427CrossRefGoogle Scholar
  29. Rockman MV, Kruglyak L (2006) Genetics of global gene expression. Nat Rev Genet 7:862–872CrossRefGoogle Scholar
  30. Roger S, Mei ZZ, Baldwin JM, Dong L, Bradley H, Baldwin SA, Surprenant A, Jiang LH (2010) Single nucleotide polymorphisms that were identified in affective mood disorders affect ATP-activated P2X7 receptor functions. J Psychiatr Res 44:347–355CrossRefGoogle Scholar
  31. Saunders BM, Fernando SL, Sluyter R, Britton WJ, Wiley JS (2003) A loss-of-function polymorphism in the human P2X7 receptor abolishes ATP-mediated killing of mycobacteria. J Immunol 171:5442–5446CrossRefGoogle Scholar
  32. Shieh CH, Heinrich A, Serchov T, van Calker D, Biber K (2014) P2X7-dependent, but differentially regulated release of IL-6, CCL2, and TNF-alpha in cultured mouse microglia. Glia 62:592–607CrossRefGoogle Scholar
  33. Skuplik I, Benito-Sanz S, Rosin JM, Bobick BE, Heath KE, Cobb J (2018) Identification of a limb enhancer that is removed by pathogenic deletions downstream of the SHOX gene. Sci Rep 8:14292CrossRefGoogle Scholar
  34. Sluyter R, Dalitz JG, Wiley JS (2004) P2X7 receptor polymorphism impairs extracellular adenosine 5′-triphosphate-induced interleukin-18 release from human monocytes. Genes Immun 5:588–591CrossRefGoogle Scholar
  35. Solini A, Simeon V, Derosa L, Orlandi P, Rossi C, Fontana A, Galli L, Di Desidero T, Fioravanti A, Lucchesi S, Coltelli L, Ginocchi L, Allegrini G, Danesi R, Falcone A, Bocci G (2015) Genetic interaction of P2X7 receptor and VEGFR-2 polymorphisms identifies a favorable prognostic profile in prostate cancer patients. Oncotarget 6:28743–28754CrossRefGoogle Scholar
  36. Sperlagh B, Illes P (2014) P2X7 receptor: an emerging target in central nervous system diseases. Trends Pharmacol Sci 35:537–547CrossRefGoogle Scholar
  37. Stranger BE, Nica AC, Forrest MS, Dimas A, Bird CP, Beazley C, Ingle CE, Dunning M, Flicek P, Koller D, Montgomery S, Tavare S, Deloukas P, Dermitzakis ET (2007) Population genomics of human gene expression. Nat Genet 39:1217–1224CrossRefGoogle Scholar
  38. Sun C, Southard C, Witonsky DB, Olopade OI, Di Rienzo A (2010) Allelic imbalance (AI) identifies novel tissue-specific cis-regulatory variation for human UGT2B15. Hum Mutat 31:99–107CrossRefGoogle Scholar
  39. Sun C, Southard C, Olopade OI, Di Rienzo A (2011) Differential allelic expression of c.1568C > A at UGT2B15 is due to variation in a novel cis-regulatory element in the 3′UTR. Gene 481:24–28CrossRefGoogle Scholar
  40. Taheri M, Sarani H, Moazeni-Roodi A, Naderi M, Hashemi M (2019) Association between P2X7 polymorphisms and susceptibility to tuberculosis: an updated meta-analysis of case-control studies. Medicina (Kaunas) 55:298CrossRefGoogle Scholar
  41. Tao H, Cox DR, Frazer KA (2006) Allele-specific KRT1 expression is a complex trait. PLoS Genet 2:e93CrossRefGoogle Scholar
  42. Thompson AC, Capellini TD, Guenther CA, Chan YF, Infante CR, Menke DB, Kingsley DM (2018) A novel enhancer near the Pitx1 gene influences development and evolution of pelvic appendages in vertebrates. Elife 7:e38555CrossRefGoogle Scholar
  43. Varley I, Greeves JP, Sale C, Friedman E, Moran DS, Yanovich R, Wilson PJ, Gartland A, Hughes DC, Stellingwerff T, Ranson C, Fraser WD, Gallagher JA (2016) Functional polymorphisms in the P2X7 receptor gene are associated with stress fracture injury. Purinergic Signal 12:103–113CrossRefGoogle Scholar
  44. Varley I, Hughes DC, Greeves JP, Fraser WD, Sale C (2018) SNPs in the vicinity of P2X7R, RANK/RANKL/OPG and Wnt signalling pathways and their association with bone phenotypes in academy footballers. Bone 108:179–185CrossRefGoogle Scholar
  45. Volonte C, Apolloni S, Skaper SD, Burnstock G (2012) P2X7 receptors: channels, pores and more. CNS Neurol Disord: Drug Targets 11:705–721CrossRefGoogle Scholar
  46. Wakx A, Dutot M, Massicot F, Mascarelli F, Limb GA, Rat P (2016) Amyloid beta peptide induces apoptosis through P2X7 cell death receptor in retinal cells: modulation by marine omega-3 fatty acid DHA and EPA. Appl Biochem Biotechnol 178:368–381CrossRefGoogle Scholar
  47. Wang PY, Huo D, Sun C, Olopade OI (2013) The use of allelic imbalance to ascertain cis-regulation for human UGT2B7 in vivo. Eur J Clin Pharmacol 69:1733–1735CrossRefGoogle Scholar
  48. Wang H, Gong C, Liu X, Rao S, Li T, He L, Nie Y, Wang S, Zhong P, Xue Y, Wang J, Zhao J, Zhou Y, Ding L, Tu Y, Yang Y, Xiong C, Liang S, Xu H (2018) Genetic interaction of purinergic P2X7 receptor and ER-alpha polymorphisms in susceptibility to osteoporosis in Chinese postmenopausal women. J Bone Miner Metab 36:488–497CrossRefGoogle Scholar
  49. Wiley JS, Sluyter R, Gu BJ, Stokes L, Fuller SJ (2011) The human P2X7 receptor and its role in innate immunity. Tissue Antigens 78:321–332CrossRefGoogle Scholar
  50. Xu H, Gong C, He L, Rao S, Liu X, Nie Y, Liu C, Li T, Ding L, Tu Y, Yang Y, Hu F, Fan Y, Wang H, Wang S, Xiong C, Zhong P, Tang L, Liang S (2017) Purinergic P2X7 receptor functional genetic polymorphisms are associated with the susceptibility to osteoporosis in Chinese postmenopausal women. Purinergic Signal 13:339–346CrossRefGoogle Scholar
  51. Yan H, Zhou W (2004) Allelic variations in gene expression. Curr Opin Oncol 16:39–43CrossRefGoogle Scholar
  52. Yan H, Yuan W, Velculescu VE, Vogelstein B, Kinzler KW (2002) Allelic variation in human gene expression. Science 297:1143CrossRefGoogle Scholar
  53. Zhang Y, Wang D, Johnson AD, Papp AC, Sadee W (2005) Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G. J Biol Chem 280:32618–32624CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.National Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest China, Key Laboratory of the Ministry of Education for Medicinal Resources and Natural Pharmaceutical Chemistry, College of Life SciencesShaanxi Normal UniversityXi’anPeople’s Republic of China
  2. 2.Department of Respiratory Critical Care MedicineThe First Affiliated Hospital of Kunming Medical UniversityKunmingPeople’s Republic of China

Personalised recommendations